Floatz logo

MELATONIN

Insomnia

Odense University HospitalSmall moleculePhase 3Active
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
89/ 100

Competitive context

9 Active assets in the Insomnia cohort.

Asset / SponsorPhaseRating
Eszopiclone
University of California, Los Angeles
Phase 4A
LEMBOREXANT
YangPan
Phase 4BBB
Suvorexant
Mayo Clinic
Phase 4BBB
Cipralex
University of California, Los Angeles
Phase 4BBB
CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-
University of California, San Diego
Phase 3BB

View all 40 →

Same molecule, other indications

MELATONIN is also rated in:

traumatic brain injuryDormant
BBB
Indicative ·
74 / 100
View asset →
bipolar disorderDormant
BBB
Indicative ·
72 / 100
View asset →
circadian rhythm sleep disorderDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →